NEUP — Neuphoria Therapeutics Share News
0.000.00%
Last trade - 00:00- $18.61m
- -$1.22m
- $1.17m
NASDAQ RESUMED AT 03:25 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:20 PM
Brief: Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell
Brief: Neuphoria Responds To Lynx1’S Revised Indication Of Interest At A Reduced Price And Premium
Brief: Neuphoria Therapeutics May Offer & Sell Common Stock Of Up To $20 Million From Time To Time - SEC Filing
Brief: Neuphoria Announces Initiation Of Strategic Review
Brief: Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan To Protect Integrity Of Process
Brief: Neuphoria Therapeutics May Offer & Sell Common Stock Of Up To $21.9 Mln From Time To Time - SEC Filing
U.S. STOCKS ON THE MOVE-RBB Bancorp, Hologic, Eversource
U.S. STOCKS ON THE MOVE-RBB Bancorp, Hologic, Eversource
U.S. STOCKS ON THE MOVE-Lockheed Martin, Truist Financial, Reddit
U.S. STOCKS ON THE MOVE-Elevance, EPAM Systems, Danaher
Neuphoria falls, scraps social anxiety program after drug trial failure
Neuphoria plunges after trial failure forces halt to anxiety drug program
U.S. RESEARCH ROUNDUP-Chewy, Phillips 66, Vimeo
Brief: Neuphoria Therapeutics Says Cash Runway Extends Into Q3 2026 - SEC Filing
Brief: Neuphoria Therapeutics Inc - Merck Pays $15M Milestone, Extends Cash Runway To Q3 2026
Neuphoria Therapeutics rises on $15 mln milestone payment from Merck
Brief: Neuphoria Therapeutics Files For Offer, Resale From Time To Time By Selling Shareholder Of Up To 1.1 Million Shares Of Common Stock